|
TPR expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.431800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.145400E-01 |
| Normal-vs-Stage2 |
2.874000E-01 |
| Normal-vs-Stage3 |
8.699600E-01 |
| Normal-vs-Stage4 |
9.669200E-01 |
| Stage1-vs-Stage2 |
8.394200E-01 |
| Stage1-vs-Stage3 |
2.718800E-01 |
| Stage1-vs-Stage4 |
5.680200E-01 |
| Stage2-vs-Stage3 |
3.210400E-01 |
| Stage2-vs-Stage4 |
5.186200E-01 |
| Stage3-vs-Stage4 |
8.944400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.561600E-01 |
| Normal-vs-AfricanAmerican |
3.197800E-01 |
| Normal-vs-Asian |
1.327580E-01 |
| Caucasian-vs-AfricanAmerican |
8.101400E-01 |
| Caucasian-vs-Asian |
6.166800E-01 |
| AfricanAmerican-vs-Asian |
6.160600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.775600E-02 |
| Normal-vs-Female |
7.992500E-02 |
| Male-vs-Female |
1.682330E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.073600E-01 |
| Normal-vs-Extreme_Weight |
2.341600E-02 |
| Normal-vs-Obese |
7.307000E-01 |
| Normal-vs-Extreme_Obese |
5.383800E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.018000E-01 |
| Normal_Weight-vs-Obese |
4.751400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.480000E-01 |
| Extreme_Weight-vs-Obese |
2.821800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.520400E-01 |
| Obese-vs-Extreme_Obese |
1.873640E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.428400E-02 |
| Normal-vs-Age(41-60Yrs) |
5.627600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.753810E-02 |
| Normal-vs-Age(81-100Yrs) |
2.401700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.113600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.700270E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.758500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.102000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.291800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.925600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.121600E-01 |
| Normal-VS-Type2 PRCC |
4.222300E-02 |
| Normal-VS-KIRP CIMP |
6.809600E-02 |
| Normal-VS-Unclassified PRCC |
9.358600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.097400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.279900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.823600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.641200E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.669360E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.029600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.101000E-03 |
| Normal-vs-N1 |
6.292300E-02 |
| Normal-vs-N2 |
1.958820E-01 |
| N0-vs-N1 |
3.357000E-03 |
| N0-vs-N2 |
5.198200E-02 |
| N1-vs-N2 |
7.565400E-01 |
|
|
